IL1B and infection: Quantification of IL-1β production in the skin of the infected mice revealed that by 72 h post-infection, none of the treatments delivered intraperitoneally were effective at reducing IL-1β levels compared to infected mice treated with only vehicle controls (Flaherty, data not shown).